In 2024, the consumption of respiratory system medicine in Finland stood at 214.3 units (Defined Daily Dosage) per thousand persons per day. This marks a notable increase from the previous year. Forecasting for the next five years indicates a consistent upward trend in usage:
- 2025: 219.5 units (+2.4% YoY)
- 2026: 224.7 units (+2.4% YoY)
- 2027: 229.9 units (+2.3% YoY)
- 2028: 235.0 units (+2.2% YoY)
Year-on-year variations have stayed around 2.2% to 2.4%, demonstrating a steady and predictable increase. Over the last two years, the average year-on-year growth stands at approximately 2.3%, and the Compound Annual Growth Rate (CAGR) for the forecasted period is around 2.3% as well.
Future trends to watch for include the potential impacts of emerging respiratory health threats, advancements in medical treatments, and public health initiatives aimed at preventing respiratory conditions. Monitoring healthcare policies and technological innovations will be crucial in predicting mid-to-long-term shifts in medication usage patterns.
